Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 194

1.

Trends in Prostate-Specific Antigen Screening and Prostate Cancer Interventions 3 Years After the U.S. Preventive Services Task Force Recommendation.

Ong MS, Mandl KD.

Ann Intern Med. 2017 Mar 21;166(6):451-452. doi: 10.7326/L16-0422. No abstract available.

PMID:
28320011
2.

Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease.

Bourgeois FT, Orenstein L, Ballakur S, Mandl KD, Ioannidis JP.

J Am Geriatr Soc. 2017 Mar 17. doi: 10.1111/jgs.14833. [Epub ahead of print]

PMID:
28306144
3.

Difference Between Estimated Purchase Price and Insurance Payments for Knee and Hip Implants in Privately Insured Patients Younger Than 65 Years.

Tseng YJ, Mandl KD.

JAMA. 2017 Feb 28;317(8):854-855. doi: 10.1001/jama.2016.19579. No abstract available.

PMID:
28245312
4.

Opening the Duke electronic health record to apps: Implementing SMART on FHIR.

Bloomfield RA Jr, Polo-Wood F, Mandel JC, Mandl KD.

Int J Med Inform. 2017 Mar;99:1-10. doi: 10.1016/j.ijmedinf.2016.12.005. Epub 2016 Dec 12.

PMID:
28118917
5.

Predicting Falls in People Aged 65 Years and Older from Insurance Claims.

Homer ML, Palmer NP, Fox KP, Armstrong J, Mandl KD.

Am J Med. 2017 Jan 20. pii: S0002-9343(17)30033-5. doi: 10.1016/j.amjmed.2017.01.003. [Epub ahead of print]

PMID:
28111165
6.

The Impact of Provider Networks on the Co-Prescriptions of Interacting Drugs: A Claims-Based Analysis.

Ong MS, Olson KL, Chadwick L, Liu C, Mandl KD.

Drug Saf. 2017 Mar;40(3):263-272. doi: 10.1007/s40264-016-0490-1.

PMID:
28000151
7.

Accelerating Scientific Advancement for Pediatric Rare Lung Disease Research. Report from a National Institutes of Health-NHLBI Workshop, September 3 and 4, 2015.

Young LR, Trapnell BC, Mandl KD, Swarr DT, Wambach JA, Blaisdell CJ.

Ann Am Thorac Soc. 2016 Dec;13(12):385-393.

PMID:
27925785
8.

Claims-Based Diagnostic Patterns of Patients Evaluated for Lyme Disease and Given Extended Antibiotic Therapy.

Tseng YJ, DeMaria A Jr, Goldmann DA, Mandl KD.

Vector Borne Zoonotic Dis. 2017 Feb;17(2):116-122. doi: 10.1089/vbz.2016.1991. Epub 2016 Nov 17.

PMID:
27855040
9.

Trends in Pharmacologic Interventions for Preventing Recurrence of Crohn's Disease After Ileocolonic Surgery.

Ong MS, Grand RJ, Mandl KD.

Inflamm Bowel Dis. 2016 Oct;22(10):2432-41. doi: 10.1097/MIB.0000000000000898.

PMID:
27631599
10.

The Drug Data to Knowledge Pipeline: Large-Scale Claims Data Classification for Pharmacologic Insight.

Homer ML, Palmer NP, Bodenreider O, Cami A, Chadwick L, Mandl KD.

AMIA Jt Summits Transl Sci Proc. 2016 Jul 20;2016:105-11. eCollection 2016.

11.

Financial competing interests were associated with favorable conclusions and greater author productivity in nonsystematic reviews of neuraminidase inhibitors.

Dunn AG, Zhou X, Hudgins J, Arachi D, Mandl KD, Coiera E, Bourgeois FT.

J Clin Epidemiol. 2016 Dec;80:43-49. doi: 10.1016/j.jclinepi.2016.07.010. Epub 2016 Jul 25.

PMID:
27460462
12.

Creating a scalable clinical pharmacogenomics service with automated interpretation and medical record result integration - experience from a pediatric tertiary care facility.

Manzi SF, Fusaro VA, Chadwick L, Brownstein C, Clinton C, Mandl KD, Wolf WA, Hawkins JB.

J Am Med Inform Assoc. 2017 Jan;24(1):74-80. doi: 10.1093/jamia/ocw052. Epub 2016 Jun 14.

PMID:
27301749
13.

Patient and Parent-Reported Signs and Symptoms for Group A Streptococcal Pharyngitis.

Lindgren C, Neuman MI, Monuteaux MC, Mandl KD, Fine AM.

Pediatrics. 2016 Jul;138(1). pii: e20160317. doi: 10.1542/peds.2016-0317. Epub 2016 Jun 8.

PMID:
27279649
14.

SMART-on-FHIR implemented over i2b2.

Wagholikar KB, Mandel JC, Klann JG, Wattanasin N, Mendis M, Chute CG, Mandl KD, Murphy SN.

J Am Med Inform Assoc. 2017 Mar 1;24(2):398-402. doi: 10.1093/jamia/ocw079.

15.

Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials.

Bourgeois FT, Olson KL, Tse T, Ioannidis JP, Mandl KD.

PLoS One. 2016 May 19;11(5):e0155948. doi: 10.1371/journal.pone.0155948. eCollection 2016.

16.
17.

C3-PRO: Connecting ResearchKit to the Health System Using i2b2 and FHIR.

Pfiffner PB, Pinyol I, Natter MD, Mandl KD.

PLoS One. 2016 Mar 31;11(3):e0152722. doi: 10.1371/journal.pone.0152722. eCollection 2016.

18.

SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care.

Warner JL, Rioth MJ, Mandl KD, Mandel JC, Kreda DA, Kohane IS, Carbone D, Oreto R, Wang L, Zhu S, Yao H, Alterovitz G.

J Am Med Inform Assoc. 2016 Jul;23(4):701-10. doi: 10.1093/jamia/ocw015. Epub 2016 Mar 27.

PMID:
27018265
19.

SMART on FHIR: a standards-based, interoperable apps platform for electronic health records.

Mandel JC, Kreda DA, Mandl KD, Kohane IS, Ramoni RB.

J Am Med Inform Assoc. 2016 Sep;23(5):899-908. doi: 10.1093/jamia/ocv189. Epub 2016 Feb 17.

PMID:
26911829
20.

Data interchange using i2b2.

Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN.

J Am Med Inform Assoc. 2016 Sep;23(5):909-15. doi: 10.1093/jamia/ocv188. Epub 2016 Feb 5.

PMID:
26911824

Supplemental Content

Loading ...
Support Center